Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Correction: Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging
    Published on 2024-09-09
    2 years ago
  • Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats
    Published on 2024-09-06
    2 years ago
  • Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression
    Published on 2024-09-06
    2 years ago
  • Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility
    Published on 2024-09-06
    2 years ago
  • Revisiting the role of computational neuroimaging in the era of integrative neuroscience
    Published on 2024-09-06
    2 years ago
  • Prenatal exposure to the mineralocorticoid receptor antagonist spironolactone disrupts hippocampal area CA2 connectivity and alters behavior in mice
    Published on 2024-09-05
    2 years ago
  • GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm
    Published on 2024-09-04
    2 years ago
« Previous 1 … 82 83 84 85 86 … 143 Next »
Journal of Psychopharmacology
  • β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice
    Published on 2022-06-20
    4 years ago
  • Pharmacological characterization of a novel putative nootropic beta-alanine derivative, MB-005, in adult zebrafish
    Published on 2022-06-17
    4 years ago
  • Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice
    Published on 2022-06-13
    4 years ago
  • Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit
    Published on 2022-06-13
    4 years ago
  • Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate
    Published on 2022-06-13
    4 years ago
  • Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019
    Published on 2022-06-13
    4 years ago
  • BAP editorial: Improving the validity and translation of preclinical research
    Published on 2022-06-10
    4 years ago
« Previous 1 … 82 83 84 85 86 … 154 Next »
European Neuropsychopharmacology
  • Barriers to managing bipolar I disorder with long-acting injectable antipsychotics
    Published on 2022-08-28
    4 years ago
  • What can lifestyle factors tell us about cognitive dysfunction in bipolar disorder?
    Published on 2022-08-28
    4 years ago
  • Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders
    Published on 2022-07-30
    4 years ago
  • Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior
    Published on 2022-07-30
    4 years ago
  • Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)
    Published on 2022-07-29
    4 years ago
  • Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management
    Published on 2022-07-27
    4 years ago
  • Early intervention and staging bipolar disorder: Conceptual and clinical dilemmas
    Published on 2022-07-27
    4 years ago
« Previous 1 … 82 83 84 85 86 … 170 Next »

   Pharma Pub